Results
34
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
34 companies
Novartis
Market Cap: CHF 184.2b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 94.03
7D
1.4%
1Y
0.9%
Merck
Market Cap: US$191.8b
Operates as a healthcare company worldwide.
MRK
US$76.84
7D
-1.0%
1Y
-38.8%
Waters
Market Cap: US$21.1b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$349.24
7D
0.8%
1Y
13.1%
Exelixis
Market Cap: US$11.6b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$43.04
7D
1.5%
1Y
98.4%
Orion Oyj
Market Cap: €8.4b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€59.75
7D
2.2%
1Y
59.4%
Abbott India
Market Cap: ₹647.1b
Operates as a pharmaceutical company in India.
500488
₹30,453.15
7D
-1.2%
1Y
17.7%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹558.2b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,295.00
7D
9.0%
1Y
25.3%
SK Biopharmaceuticals
Market Cap: ₩7.3t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩93,000.00
7D
3.6%
1Y
8.9%
Xiamen Amoytop Biotech
Market Cap: CN¥31.4b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥77.25
7D
3.6%
1Y
41.4%
Agios Pharmaceuticals
Market Cap: US$1.9b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$32.09
7D
7.7%
1Y
-11.7%
BioArctic
Market Cap: SEK 16.1b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 181.90
7D
1.1%
1Y
-25.0%
Sanofi India
Market Cap: ₹143.0b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹6,208.95
7D
-0.9%
1Y
-28.1%
Procter & Gamble Health
Market Cap: ₹95.9b
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
500126
₹5,775.85
7D
6.8%
1Y
22.4%
Neuren Pharmaceuticals
Market Cap: AU$1.7b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$13.88
7D
7.8%
1Y
-35.9%
Philogen
Market Cap: €902.5m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases.
PHIL
€22.40
7D
0%
1Y
5.7%
Jeena Sikho Lifecare
Market Cap: ₹53.0b
Trades in ayurvedic medicines in India.
JSLL
₹2,132.25
7D
0.4%
1Y
96.3%
L&C BIOLTD
Market Cap: ₩653.6b
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩28,200.00
7D
-7.8%
1Y
49.2%
Ever Supreme Bio Technology
Market Cap: NT$13.6b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$171.00
7D
-0.3%
1Y
-12.3%
PharmaEngine
Market Cap: NT$13.0b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$90.30
7D
-2.3%
1Y
-0.3%
RPG Life Sciences
Market Cap: ₹36.1b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,181.20
7D
-0.3%
1Y
52.7%
Puma Biotechnology
Market Cap: US$167.8m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.28
7D
1.4%
1Y
-14.8%
MPH Health Care
Market Cap: €92.0m
An investment company, engages in the healthcare business in Germany.
93M1
€21.50
7D
-15.4%
1Y
-36.4%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft36.5b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,640.00
7D
2.3%
1Y
9.1%
JW Shinyak
Market Cap: ₩91.3b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,715.00
7D
10.6%
1Y
3.3%
Ind-Swift Laboratories
Market Cap: ₹4.8b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.
INDSWFTLAB
₹81.18
7D
12.4%
1Y
-22.4%
EZZ Life Science Holdings
Market Cap: AU$73.8m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.57
7D
4.0%
1Y
46.9%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م2.2b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م431.20
7D
2.2%
1Y
97.1%
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫1.0t
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫112,000.00
7D
0%
1Y
28.7%
China SXT Pharmaceuticals
Market Cap: US$22.3m
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
SXTC
US$1.39
7D
-10.3%
1Y
-83.5%
Arab Drug
Market Cap: ج.م1.0b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م171.93
7D
-1.6%
1Y
82.5%
Celemics
Market Cap: ₩27.5b
Designs, manufactures, and distributes sequencing kits in South Korea.
A331920
₩3,370.00
7D
6.5%
1Y
-11.4%
Genesis IBRC India
Market Cap: ₹250.3m
Does not have significant operations.
514336
₹19.25
7D
0%
1Y
n/a
Scinai Immunotherapeutics
Market Cap: US$2.5m
A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.
SCNI
US$2.72
7D
-1.4%
1Y
-27.5%
Captor Capital
Market Cap: CA$1.5m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.45
7D
0%
1Y
-25.8%